|
TRIM35 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.325400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.979800E-03 |
| Normal-vs-Stage2 |
8.678800E-01 |
| Normal-vs-Stage3 |
5.910600E-01 |
| Normal-vs-Stage4 |
4.796200E-01 |
| Stage1-vs-Stage2 |
1.714240E-02 |
| Stage1-vs-Stage3 |
1.699460E-03 |
| Stage1-vs-Stage4 |
1.159490E-03 |
| Stage2-vs-Stage3 |
7.791400E-01 |
| Stage2-vs-Stage4 |
6.540200E-01 |
| Stage3-vs-Stage4 |
8.576400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.491000E-01 |
| Normal-vs-AfricanAmerican |
5.733400E-01 |
| Normal-vs-Asian |
6.878400E-01 |
| Caucasian-vs-AfricanAmerican |
8.622800E-01 |
| Caucasian-vs-Asian |
9.881000E-01 |
| AfricanAmerican-vs-Asian |
9.559000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.471800E-01 |
| Normal-vs-Female |
5.932400E-02 |
| Male-vs-Female |
1.048560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.316800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.471000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.158400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.082600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.575800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.069000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.887000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.767600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.596800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.211400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.863140E-03 |
| Normal-vs-Grade 2 |
1.091710E-02 |
| Normal-vs-Grade 3 |
9.554400E-01 |
| Normal-vs-Grade 4 |
3.191600E-01 |
| Grade 1-vs-Grade 2 |
1.731960E-01 |
| Grade 1-vs-Grade 3 |
2.243000E-03 |
| Grade 1-vs-Grade 4 |
3.337900E-03 |
| Grade 2-vs-Grade 3 |
4.618800E-03 |
| Grade 2-vs-Grade 4 |
1.979660E-03 |
| Grade 3-vs-Grade 4 |
3.437400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.400800E-03 |
| Normal-vs-ccB subtype |
7.730600E-01 |
| ccA subtype-vs-ccB subtype |
1.016100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.870200E-01 |
| Normal-vs-N1 |
8.526400E-01 |
| N0-vs-N1 |
5.597000E-01 |
|
|
